SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-22-050817
Filing Date
2022-04-27
Accepted
2022-04-27 10:52:19
Documents
2
Group Members
ALEX NOAH INVESTORS, INC.JONATHAN I. COPEJOSHUA B. SCHEINFELDLINCOLN PARK CAPITAL, LLCROCKLEDGE CAPITAL CORP

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2213725d1_sc13g.htm SC 13G 103740
2 EXHIBIT 1 tm2213725d1_ex1.htm EX-99.1 12156
  Complete submission text file 0001104659-22-050817.txt   117713
Mailing Address 440 NORTH WELLS STREET SUITE 410 CHICAGO IL 60654
Business Address 440 NORTH WELLS STREET SUITE 410 CHICAGO IL 60654 312-822-9300
Lincoln Park Capital Fund, LLC (Filed by) CIK: 0001592644 (see all company filings)

IRS No.: 010939472 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Subject) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88731 | Film No.: 22857308
SIC: 2834 Pharmaceutical Preparations